Filing Details

Accession Number:
0001140361-18-000921
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-04 20:16:43
Reporting Period:
2018-01-02
Accepted Time:
2018-01-04 20:16:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247681 Bryan V Lawlis C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-02 3,750 $38.59 18,610 No 4 M Direct
Common Stock Disposition 2018-01-02 3,750 $88.84 14,860 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy Common Stock) Disposition 2018-01-02 3,750 $0.00 3,750 $38.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,750 2008-11-22 2018-05-21 No 4 M Direct
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.
  2. Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017.
  3. All shares sold at the same price.
  4. Reflects the number of stock options outstanding after the transaction from this specific stock option grant.